CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
30 hedge funds and large institutions have $12.1M invested in Cymabay Therapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
70% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 10
Holders
30
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$68.4K | |
| 2 | +$67.7K | |
| 3 | +$15K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.58K |
| 5 |
Barclays
London,
United Kingdom
|
+$1K |
Top Sellers
| 1 | -$709K | |
| 2 | -$543K | |
| 3 | -$508K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$258K |
| 5 |
PVI
Pura Vida Investments
New York
|
-$195K |